Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
Posted on: Wednesday, 3 June 2009, 09:38 CDT
The Finzi Fellowship program seeks to cultivate an interest in a career in lupus research among young investigators by supporting basic, clinical, and psychosocial research studies. The program is part of the LFA's ongoing efforts to advance the science and medicine of lupus and bring down barriers that have impeded progress in research on the disease. In the past, medical research on lupus has not kept pace with efforts for other similar chronic and life-threatening diseases. The FDA has not approved a drug for lupus in 50 years.
The five 2009 Gina M. Finzi Fellowship recipients and their studies are:
"Accelerated Atherosclerosis and Pro-Inflammatory HDL in SLE-prone Mice"
"Cyclooxygenase 2 and Injury in Neonatal Lupus"
"Putative Mechanism of NP-SLE: Toxicity of Anti-DNA Anti-NMDAR Antibody"
"Psychological and Disease Related Predictors of Sleep in Pediatric SLE"
"Analysis of SLE Clinical Characteristics Using SLE Susceptibility Genes"
The Foundation's national research program, Bringing Down the Barriers, also supports important studies in areas of research that have been neglected or underfunded in the past, including pediatric/adolescent lupus, lupus in males, and mid-to-late stage translational research. The program also provides research grants for cutaneous (skin) lupus, kidney disease and lupus, and the cognitive effects of lupus. The program is made possible in part through donations from individuals, corporations, foundations, and a nationwide network of LFA chapters and support groups. In addition, LFA advocates have been effective in advancing lupus research and education programs conducted by the federal government, and secured millions of additional research dollars for studies on lupus supported through the National Institutes of Health, the Department of Defense, and the Centers for Disease Control and Prevention.
About Lupus
Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two to three times more common among African Americans, Hispanics/Latinos, Native Americans, and Asians.
About the Lupus Foundation of America
The LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. Founded in 1977, the LFA has a nationwide network of nearly 300 chapters and support groups and operates programs of research, education, and advocacy. For further information about LFA's National Research Program, please contact
SOURCE Lupus Foundation of America
Source: PR Newswire
Related Articles
- NephCure Foundation Announces Research Grant Program Recipients
- Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
- Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
- Aethlon Medical Signs Cooperative Research and Development Agreement With The U.S. Army Medical Research Institute of Infectious Diseases
- Savient Pharmaceuticals Announces Official Support of the American College of Rheumatology Research and Education Foundation's Annual 5K Run/Walk
- University Hospitals of Cleveland Receives $250,000 Grant for Breast Cancer Research From Komen Foundation
- Foundation for Clinical Research in Inflammatory Bowel Disease Launches MyIBD.Org
- Green Tea Ingredient Protects Brain Against Alzheimer's Disease: Study
- National Quality Care, Inc. Enters into Research Agreement With Technion Research and Development Foundation
 |
 |
User Comments (0)
RSS Feeds